All-trans-retinoic Acid Promotes Iodine Uptake Via Up-regulating the Sodium Iodide Symporter in Medullary Thyroid Cancer Stem Cells |
Tang, Min
(Department of Radiation Medicine, The First Affiliated Hospital, Chongqing Medical University)
Hou, Yan-Li (Department of Radiation Medicine, The First Affiliated Hospital, Chongqing Medical University) Kang, Qiang-Qiang (Department of Radiation Medicine, The First Affiliated Hospital, Chongqing Medical University) Chen, Xing-Yue (Department of Radiation Medicine, The First Affiliated Hospital, Chongqing Medical University) Duan, Li-Qun (Department of Radiation Medicine, The First Affiliated Hospital, Chongqing Medical University) Shu, Jin (Department of Radiation Medicine, The First Affiliated Hospital, Chongqing Medical University) Li, Shao-Lin (Department of Radiation Medicine, The First Affiliated Hospital, Chongqing Medical University) Hu, Xiao-Li (Department of Nuclear Medical, The First Affiliated Hospital, Chongqing Medical University) Peng, Zhi-Ping (Department of Radiation Medicine, The First Affiliated Hospital, Chongqing Medical University) |
1 | Martin LP, Hamilton TC, Schilder RJ (2008). Platinum resistance: the role of DNA repair pathways. Clin Cancer Res, 14, 1291-5. DOI ScienceOn |
2 | Doha'n O, Carrasco N (2003). Advances in Na (+)/I (-) symporter (NIS) research in the thyroid and beyond. Mol Cell Endocrinol, 213, 59-70. DOI ScienceOn |
3 | Collins SJ (2002). The role of retinoids and retinoic acid receptors in normal hematopoiesis. Leukemia, 16, 1896-905. DOI ScienceOn |
4 | Damle N, Patnecha M, Kumar P, et al (2011). Retinoic acid therapy in patients with radioiodine negative differentiated thyroid cancer and clinical or biochemical evidence of disease: An initial experience. Indian J Nucl Med, 26, 144-8. DOI ScienceOn |
5 | Doha'n O, De la Vieja A, Paroder V, et al (2003). The sodium/ iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev, 24, 48-77. DOI ScienceOn |
6 | Elola M, Yoldi A, Emparanza JI, et al (2011). Redifferentiation therapy with rosiglitazone in a case of differentiated thyroid cancer with pulmonary metastases and absence of radioiodine uptake. Rev Esp Med Nucl, 30, 241-3. DOI ScienceOn |
7 | Foujilas C, Marakaki C, Sirmos N (2009). Sodium-iodine symporter in thyroid, normal and cancer tissues and its relation to nuclear medicine and to gene cloning treatment. Hell J Nucl Med, 12, 189-93. |
8 | Francipane MG, Chandler J, Lagasse E (2013). Cancer stem cells: a moving target. Curr Pathobiol Rep, 1, 111-8. DOI ScienceOn |
9 | Hadnagy A, Gaboury L, Beaulieu R, Balicki D (2006). SP analysis may be used to identify cancer stem cell populations. Exp Cell Res, 312, 3701-10. DOI ScienceOn |
10 | Jiang W, Peng J, Zhang Y, et al (2012). The implications of cancer stem cells for cancer therapy. Int J Mol Sci, 13, 16636-57. DOI ScienceOn |
11 | Tseng LM, Huang PI, Chen YR, et al (2012). Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells. J Pharmacol Exp Ther, 341, 410-23. DOI |
12 | Weiss SJ, Philp NJ, Grollman EF (1984). Iodide transport in a continuous line of cultured cells from rat thyroid. Endocrinology, 114, 1090-8. DOI ScienceOn |
13 | Yu J, Vodyanik MA, Smuga-Otto K, et al (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917-20. DOI ScienceOn |
14 | Jordan CT, Guzman ML, Noble M (2006). Cancer stem cells. N Engl J Med, 355, 1253-61. DOI ScienceOn |
15 | Lin RY (2011). Thyroid cancer stem cells. Nat Rev Endocrinol, 7, 609-16. DOI ScienceOn |
16 | Lobo NA, Shimono Y, Qian D, et al (2007). The biology of cancer stem cells. Annu Rev Dev Bio, 23, 675-99. DOI ScienceOn |
17 | Rashidi A, Goudar RK, Sayedian F, et al (2013). All-trans retinoic acid and early mortality in acute promyelocytic leukemia. Leuk Res, 37, 1391-2. DOI ScienceOn |
18 | Reya T, Morrison SJ, Clarke MF, et al (2001). Weissman IL. Stem cells and cancer stem cells. Nature, 414, 105-11. DOI ScienceOn |
19 | Ryan J, Curran CE, Hennessy E, et al (2011). The sodium iodide symporter (NIS) and potential regulators in normal, benign and malignant human breast tissue. PLoS One, 6, e16023. DOI ScienceOn |
20 | Schmutzler C, Winzer R, Meissner-Weigl J, et al (1997). Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells. Biochem Biophys Res Commun, 240, 832-8. DOI ScienceOn |
21 | Segalla S, Rinaldi L, Kilstrup-Nielsen C, et al (2003). Retinoic acid receptor alpha fusion to PML affects its transcriptional and chromatin-remodeling properties. Mol Cell Biol, 23, 8795-808. DOI ScienceOn |
22 | Tabarestani S, Ghafouri-Fard S (2012). Cancer stem cells and response to therapy. Asian Pac J Cancer Prev, 13, 5947-54. DOI ScienceOn |
23 | Takahashi K, Yamanaka S (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-76. DOI ScienceOn |
24 | Baumann M, Krause M, Hill R (2008). Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer, 8, 545-54. DOI ScienceOn |
25 | Biermann K, Biersack HJ, Sabet A, et al (2011). Alternative therapeutic approaches in the treatment of primary and secondary dedifferentiated and medullarythyroid carcinoma. Semin Nucl Med, 41, 139-48. DOI ScienceOn |
26 | Ailles LE, Weissman IL (2007). Cancer stem cell in solid tumor. Curr Opin Biotechnol, 18, 460-6. DOI ScienceOn |
27 | Bao S, Wu Q, McLendon RE, et al (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 444, 756-60. DOI ScienceOn |
28 | Christina Zechel (2005). Requirement of retinoic acid receptor isotypes alpha, beta and gamma during the initial steps of neural differentiation of PCC7 cells. Mol Endocrinol, 19, 1629-45. DOI ScienceOn |
29 | Tomita A, Kiyoi H, Naoe T (2013). Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O 3) in acute promyelocytic leukemia. In J Hematol, 97, 717-25. |
30 | Zhang AM, Fan Y, Yao Q, et al (2012).Identification of a cancer stem-like population in the Lewis lung cancer cell line. Asian Pacific J Cancer Prev, 13, 761-6. DOI ScienceOn |
31 | Cunha De Santis G, Tamarozzi MB, Sousa RB, et al (2007). Adhesion molecules and differentiation syndrome: phenotypic and functional analysis of the effect of ATRA, , phenylbutyrate, and G-CSF in acute promyelocytic leukemia. Haematologica, 92, 1615-22. DOI ScienceOn |